Cochlear (ASX:COH)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cochlear.
RELATED STOCKHEAD STORIES
Health Check: Relax! Tariffs shape as the next Y2K as biotechs report ‘nothing to see here’
Health Check: We’re ‘duty free’, declare several ASX life science companies
Made in Australia: ASX firms boosting local health and medical manufacturing
Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much
Criterion: Counting the cost of corporate misadventure goes beyond the financials
Scott Power: ASX health stocks feel force of market volatility
Health Check: More healthcare ‘reverse ferrets’ from Trump’s razor gang
Health Check: Half-price sale as brokers ring the bell on Neuren shares
Criterion: Rollercoaster price movements are now part of the profit-reporting landscape
Scott Power: ASX healthcare stocks fall in ‘worst reporting season for a long time’
Dr Boreham’s Crucible: This hearing-aid stock is well tuned in to an evolving, competitive field
Health Check: Brokers slash Cochlear valuations as customers hold tight on product upgrades
Closing Bell: ASX ends week in decent nick; Trump-Putin talks lift spirits
